
Gregory W. Adams
Examiner (ID: 10156, Phone: (571)272-8101 , Office: P/3652 )
| Most Active Art Unit | 3652 |
| Art Unit(s) | 3652 |
| Total Applications | 1773 |
| Issued Applications | 1188 |
| Pending Applications | 87 |
| Abandoned Applications | 517 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5552976
[patent_doc_number] => 20090286962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'CHIMERIC ANTIBODIES WITH PART NEW WORLD PRIMATE BINDING REGIONS'
[patent_app_type] => utility
[patent_app_number] => 12/158034
[patent_app_country] => US
[patent_app_date] => 2006-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10041
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20090286962.pdf
[firstpage_image] =>[orig_patent_app_number] => 12158034
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/158034 | CHIMERIC ANTIBODIES WITH PART NEW WORLD PRIMATE BINDING REGIONS | Dec 19, 2006 | Abandoned |
Array
(
[id] => 5385183
[patent_doc_number] => 20090226428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'Anti-inflammatory dab'
[patent_app_type] => utility
[patent_app_number] => 11/659009
[patent_app_country] => US
[patent_app_date] => 2006-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7172
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226428.pdf
[firstpage_image] =>[orig_patent_app_number] => 11659009
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/659009 | Anti-inflammatory dAb | Dec 19, 2006 | Issued |
Array
(
[id] => 7490097
[patent_doc_number] => 08030066
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-04
[patent_title] => 'Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites'
[patent_app_type] => utility
[patent_app_number] => 11/612445
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 76
[patent_no_of_words] => 100028
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/030/08030066.pdf
[firstpage_image] =>[orig_patent_app_number] => 11612445
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/612445 | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites | Dec 17, 2006 | Issued |
Array
(
[id] => 5246957
[patent_doc_number] => 20070243191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'ANTI-HYPERPROLIFERATIVE THERAPIES TARGETING HDGF'
[patent_app_type] => utility
[patent_app_number] => 11/611554
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 35961
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20070243191.pdf
[firstpage_image] =>[orig_patent_app_number] => 11611554
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/611554 | ANTI-HYPERPROLIFERATIVE THERAPIES TARGETING HDGF | Dec 14, 2006 | Abandoned |
Array
(
[id] => 5336766
[patent_doc_number] => 20090053230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'ANTI-OX40L ANTIBODIES AND METHODS USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/097733
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 40684
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053230.pdf
[firstpage_image] =>[orig_patent_app_number] => 12097733
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/097733 | Anti-OX40L antibodies and methods using same | Dec 14, 2006 | Issued |
Array
(
[id] => 4481643
[patent_doc_number] => 07901682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-08
[patent_title] => 'Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation'
[patent_app_type] => utility
[patent_app_number] => 11/638730
[patent_app_country] => US
[patent_app_date] => 2006-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 52647
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/901/07901682.pdf
[firstpage_image] =>[orig_patent_app_number] => 11638730
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/638730 | Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation | Dec 12, 2006 | Issued |
Array
(
[id] => 5373696
[patent_doc_number] => 20090311257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'HUMAN ANTIBODIES SPECIFIC FOR GASTRIN MATERIALS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/293890
[patent_app_country] => US
[patent_app_date] => 2006-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 38437
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311257.pdf
[firstpage_image] =>[orig_patent_app_number] => 12293890
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/293890 | Human antibodies specific for gastrin materials and methods | Dec 12, 2006 | Issued |
Array
(
[id] => 5220235
[patent_doc_number] => 20070161546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Methods and compositions for treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/636843
[patent_app_country] => US
[patent_app_date] => 2006-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17049
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20070161546.pdf
[firstpage_image] =>[orig_patent_app_number] => 11636843
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/636843 | Methods and compositions for treatment of cancer | Dec 10, 2006 | Abandoned |
Array
(
[id] => 5428117
[patent_doc_number] => 20090087427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'BIOLOGICAL MATERIALS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/097193
[patent_app_country] => US
[patent_app_date] => 2006-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13365
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20090087427.pdf
[firstpage_image] =>[orig_patent_app_number] => 12097193
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/097193 | ICAM-1 binding antibodies | Dec 7, 2006 | Issued |
Array
(
[id] => 7712756
[patent_doc_number] => 08093362
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-10
[patent_title] => 'Anti-PERP recombinant antibody'
[patent_app_type] => utility
[patent_app_number] => 11/634209
[patent_app_country] => US
[patent_app_date] => 2006-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 41021
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/093/08093362.pdf
[firstpage_image] =>[orig_patent_app_number] => 11634209
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/634209 | Anti-PERP recombinant antibody | Dec 5, 2006 | Issued |
Array
(
[id] => 4628914
[patent_doc_number] => 08007796
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'Means and methods for the treatment of tumorous diseases'
[patent_app_type] => utility
[patent_app_number] => 12/095951
[patent_app_country] => US
[patent_app_date] => 2006-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21976
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/007/08007796.pdf
[firstpage_image] =>[orig_patent_app_number] => 12095951
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095951 | Means and methods for the treatment of tumorous diseases | Nov 28, 2006 | Issued |
| 10/588124 | Carcinostatic Method Using Brca1-Bard1 Pathway | Nov 16, 2006 | Abandoned |
Array
(
[id] => 5322941
[patent_doc_number] => 20090060931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING OVARIAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/093908
[patent_app_country] => US
[patent_app_date] => 2006-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12191
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20090060931.pdf
[firstpage_image] =>[orig_patent_app_number] => 12093908
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/093908 | Pharmaceutical composition for treating or preventing ovarian cancer | Nov 15, 2006 | Issued |
Array
(
[id] => 5056319
[patent_doc_number] => 20070059241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Neutralizing human anti-IGFR antibody'
[patent_app_type] => utility
[patent_app_number] => 11/598520
[patent_app_country] => US
[patent_app_date] => 2006-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26877
[patent_no_of_claims] => 114
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059241.pdf
[firstpage_image] =>[orig_patent_app_number] => 11598520
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/598520 | Neutralizing human anti-IGFR antibody | Nov 12, 2006 | Issued |
| 11/595699 | Methods and compositions for characterization of HSD1 inhibitors | Nov 8, 2006 | Abandoned |
Array
(
[id] => 795572
[patent_doc_number] => 07429486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-30
[patent_title] => 'Recombinant production of mixtures of antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/593279
[patent_app_country] => US
[patent_app_date] => 2006-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 36
[patent_no_of_words] => 34034
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/429/07429486.pdf
[firstpage_image] =>[orig_patent_app_number] => 11593279
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/593279 | Recombinant production of mixtures of antibodies | Nov 5, 2006 | Issued |
Array
(
[id] => 5126598
[patent_doc_number] => 20070238869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'CDR-grafted anti-tissue factor antibodies and methods of uses there of'
[patent_app_type] => utility
[patent_app_number] => 11/591361
[patent_app_country] => US
[patent_app_date] => 2006-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 12827
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238869.pdf
[firstpage_image] =>[orig_patent_app_number] => 11591361
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/591361 | CDR-grafted anti-tissue factor antibodies and methods of uses there of | Oct 31, 2006 | Issued |
Array
(
[id] => 5182563
[patent_doc_number] => 20070053909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'METHOD OF TREATING FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 11/552857
[patent_app_country] => US
[patent_app_date] => 2006-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17864
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053909.pdf
[firstpage_image] =>[orig_patent_app_number] => 11552857
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/552857 | METHOD OF TREATING FIBROSIS | Oct 24, 2006 | Abandoned |
Array
(
[id] => 602580
[patent_doc_number] => 07432343
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-07
[patent_title] => 'Diagnostic application of mail'
[patent_app_type] => utility
[patent_app_number] => 11/585030
[patent_app_country] => US
[patent_app_date] => 2006-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 9
[patent_no_of_words] => 24757
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/432/07432343.pdf
[firstpage_image] =>[orig_patent_app_number] => 11585030
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/585030 | Diagnostic application of mail | Oct 22, 2006 | Issued |
Array
(
[id] => 4515846
[patent_doc_number] => 07910708
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-22
[patent_title] => 'Anti-IL13 human antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/091020
[patent_app_country] => US
[patent_app_date] => 2006-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25677
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/910/07910708.pdf
[firstpage_image] =>[orig_patent_app_number] => 12091020
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/091020 | Anti-IL13 human antibodies | Oct 18, 2006 | Issued |